TwoXAR: 1ST Biotherapeutics and twoXAR Advance Three Novel Glioblastoma Treatment Candidates into In Vivo Testing in Less Than One Year
Partnership Combines Shared Drug Discovery Expertise with Integrated Artificial Intelligence to Identify Promising Targets in Half the Time of Traditional R&D Approaches
Read full article »
twoXAR is an AI-based platform that offers drug discovery, biomedical informatics, predictive analytics and preclinical validation solutions.
Read more